The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.
Lung cancer: analysis of biomarkers and methods of diagnostic and prognostic value
Corresponding Author(s) : S. S. Divya Ravali
ssdivyaravali@gmail.com
Cellular and Molecular Biology,
Vol. 63 No. 6: International conference on translational biotechnology- Biosangam
Abstract
This paper summarizes the overwhelming evidence that targeted therapy is better than chemotherapy for the treatment of lung cancer. The focus is on lung cancer because of the sheer magnitude of this disease especially in males. In India, lung cancer constitutes 6.9 per cent of all new cancer cases and 9.3 per cent of all cancer related deaths in both sexes (1). Currently the world we reside has a norm of developing cure to an abnormal state of living body (so called disease) based on evidences, recognized during the diagnosis of the disease. It is done to ensure optimized therapy of treatment and maximize the outcome. Personalized medicine is also an uprising norm. In this kind, all the variables such as host, environment, patient, etc. are considered for an individual case and the course of treatment is followed based on the standard options available. Its main objective is the best interest of the patient. Through a survey conducted in the northern belt of the country we tried to determine the biomarkers currently being used and the scope of targeted therapy. Thus, in its most basic form medicine is not only a science but is also an art.
Keywords
Biomarkers
Bhemotherapy
Targeted-therapy
Oncology
Prognosis
Non-small cell lung cancer (NSCLC).
Yadav, S., Agrawal, S., Divya Ravali, S. S., & Pandey, A. (2017). Lung cancer: analysis of biomarkers and methods of diagnostic and prognostic value. Cellular and Molecular Biology, 63(6), 88–92. https://doi.org/10.14715/cmb/2017.63.6.18
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
